Compared with low FAP expression, the pooled analyses of the two pancreatic cancer studies indicated that FAP overexpression was associated with a greater detrimental outcome (HR: 3.18, 95% CI: 1.42–7.12, P = 0.005). This evidence concerns the gene FAP and familial pancreatic carcinoma.